Home » Topics » Regulatory

Regulatory
RSS

High-dose Rebif recommended for early first-line treatment of relapsing-remitting MS

Feb. 7, 2001

Schering-Plough seeks FDA approval for PEG-Intron/Rebetol combination

Feb. 7, 2001

FDA extends approval of Toprol-XL to include heart failure

Feb. 7, 2001

FDA approves tablet formulation of CollaGenex's Periostat

Feb. 6, 2001

Formulation of glibenclamide with excellent percutaneous absorption

Feb. 6, 2001

Orion claims new use for levosimendan

Feb. 6, 2001

E.U. approves Remicade for broader RA indication

Feb. 6, 2001

Compositions and methods of treating obesity claimed by Knoll

Feb. 5, 2001

FDA issues approvable letter for Visudyne

Feb. 5, 2001

FDA approves vagus nerve stimulation trial for anxiety disorders

Feb. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...